Terms: = Astrocytoma AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Treatment
659 results:
1. A syngeneic spontaneous zebrafish model of
Weiss A; D'Amata C; Pearson BJ; Hayes MN
Elife; 2024 Jul; 13():. PubMed ID: 39052000
[TBL] [Abstract] [Full Text] [Related]
2. Mutations in glioblastoma proteins do not disrupt epitope presentation and recognition, maintaining a specific CD8 T cell immune response potential.
Tarabini RF; Fioravanti Vieira G; Rigo MM; de Souza APD
Sci Rep; 2024 Jul; 14(1):16721. PubMed ID: 39030304
[TBL] [Abstract] [Full Text] [Related]
3. ATM inhibition exploits checkpoint defects and ATM-dependent double strand break repair in tp53-mutant glioblastoma.
Laverty DJ; Gupta SK; Bradshaw GA; Hunter AS; Carlson BL; Calmo NM; Chen J; Tian S; Sarkaria JN; Nagel ZD
Nat Commun; 2024 Jun; 15(1):5294. PubMed ID: 38906885
[TBL] [Abstract] [Full Text] [Related]
4. IMPDH Inhibition Decreases TERT Expression and Synergizes the Cytotoxic Effect of Chemotherapeutic Agents in Glioblastoma Cells.
Liu X; Wang J; Wu LJ; Trinh B; Tsai RYL
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892179
[TBL] [Abstract] [Full Text] [Related]
5. Reprogramming Glioblastoma Cells into Non-Cancerous Neuronal Cells as a Novel Anti-Cancer Strategy.
Jiang MQ; Yu SP; Estaba T; Choi E; Berglund K; Gu X; Wei L
Cells; 2024 May; 13(11):. PubMed ID: 38891029
[TBL] [Abstract] [Full Text] [Related]
6. Metastatic glioblastoma to the lungs: a case report and literature review.
Yuen CA; Pekmezci M; Bao S; Kong XT
CNS Oncol; 2024 Jun; 13(1):2351789. PubMed ID: 38864820
[TBL] [Abstract] [Full Text] [Related]
7. Racial Disparities in Glioblastoma Genomic Alterations: A Comprehensive Analysis of a Multi-Institution Cohort of 2390 Patients.
John D; Alshalalfa M; Almeida T; Murray A; Marques J; Azzam G; Mellon EA; Benjamin CG; Komotar RJ; Ivan M; Mahal B; Rich BJ
World Neurosurg; 2024 Aug; 188():e625-e630. PubMed ID: 38843966
[TBL] [Abstract] [Full Text] [Related]
8. Exposure to Low-Frequency Radiation Changes the Expression of Nestin, VEGF, BCRP and Apoptosis Markers During Glioma treatment Strategy: An
Amirinejad M; Eftekhar-Vaghefi SH; Nematollahi Mahani SN; Salari M; Yahyapour R; Ahmadi-Zeidabadi M
Curr Radiopharm; 2024; 17(1):55-67. PubMed ID: 38817005
[TBL] [Abstract] [Full Text] [Related]
9. Novel 9-Methylanthracene Derivatives as p53 Activators for the treatment of Glioblastoma Multiforme.
Feng Y; Wang Y; Li X; Sun Z; Qiang S; Wang H; Liu Y
Molecules; 2024 May; 29(10):. PubMed ID: 38792257
[TBL] [Abstract] [Full Text] [Related]
10. Principles in the Management of Glioblastoma.
Roda D; Veiga P; Melo JB; Carreira IM; Ribeiro IP
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674436
[TBL] [Abstract] [Full Text] [Related]
11. DKK3 Expression in Glioblastoma: Correlations with Biomolecular Markers.
Caffo M; Casili G; Caruso G; Barresi V; Campolo M; Paterniti I; Minutoli L; Ius T; Esposito E
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612910
[TBL] [Abstract] [Full Text] [Related]
12. Glioblastoma Therapy: Past, Present and Future.
Obrador E; Moreno-Murciano P; Oriol-Caballo M; López-Blanch R; Pineda B; Gutiérrez-Arroyo JL; Loras A; Gonzalez-Bonet LG; Martinez-Cadenas C; Estrela JM; Marqués-Torrejón MÁ
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473776
[TBL] [Abstract] [Full Text] [Related]
13. CDKN2A promoter methylation enhances self-renewal of glioblastoma stem cells and confers resistance to carmustine.
Wang J; Xi YF; Zhao Q; Guo JH; Zhang Z; Zhang MB; Chang J; Wu YQ; Su W
Mol Biol Rep; 2024 Mar; 51(1):385. PubMed ID: 38438773
[TBL] [Abstract] [Full Text] [Related]
14. Genotoxic and Cytotoxic Activity of Fisetin on Glioblastoma Cells.
Beltzig L; Christmann M; Dobreanu M; Kaina B
Anticancer Res; 2024 Mar; 44(3):901-910. PubMed ID: 38423634
[TBL] [Abstract] [Full Text] [Related]
15. Aberrant ATM signaling and homology-directed DNA repair as a vulnerability of p53-mutant GBM to AZD1390-mediated radiosensitization.
Chen J; Laverty DJ; Talele S; Bale A; Carlson BL; Porath KA; Bakken KK; Burgenske DM; Decker PA; Vaubel RA; Eckel-Passow JE; Bhargava R; Lou Z; Hamerlik P; Harley B; Elmquist WF; Nagel ZD; Gupta SK; Sarkaria JN
Sci Transl Med; 2024 Feb; 16(734):eadj5962. PubMed ID: 38354228
[TBL] [Abstract] [Full Text] [Related]
16. Comparative assessment of direct and indirect cold atmospheric plasma effects, based on helium and argon, on human glioblastoma: an in vitro and in vivo study.
Bakhtiyari-Ramezani M; Nohekhan M; Akbari ME; Abbasvandi F; Bayat M; Akbari A; Nasiri M
Sci Rep; 2024 Feb; 14(1):3578. PubMed ID: 38347045
[TBL] [Abstract] [Full Text] [Related]
17. Rise of oligodendroglioma hypermutator phenotype from a subclone harboring tp53 mutation after TMZ treatment.
Higuchi F; Uzuka T; Matsuda H; Sumi T; Iwata K; Namatame T; Shin M; Akutsu H; Ueki K
Brain Tumor Pathol; 2024 Apr; 41(2):80-84. PubMed ID: 38294664
[TBL] [Abstract] [Full Text] [Related]
18. Expression of molecular markers and synergistic anticancer effects of chemotherapy with antimicrobial peptides on glioblastoma cells.
Chernov AN; Kim AV; Skliar SS; Fedorov EV; Tsapieva AN; Filatenkova TA; Chutko AL; Matsko MV; Galimova ES; Shamova OV
Cancer Chemother Pharmacol; 2024 May; 93(5):455-469. PubMed ID: 38280033
[TBL] [Abstract] [Full Text] [Related]
19. Involvement of the tumour necrosis factor receptor system in glioblastoma cell death induced by palbociclib-heptamethine cyanine dye conjugate.
Cooper E; Oyagawa CRM; Johnson R; Choi PJ; Foliaki JM; Correia J; Schweder P; Heppner P; Mee E; Turner C; Faull R; Denny WA; Dragunow M; Jose J; Park TI
Cell Commun Signal; 2024 Jan; 22(1):30. PubMed ID: 38212807
[TBL] [Abstract] [Full Text] [Related]
20. "De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade.
Hadad S; Gupta R; Oberheim Bush NA; Taylor JW; Villanueva-Meyer JE; Young JS; Wu J; Ravindranathan A; Zhang Y; Warrier G; McCoy L; Shai A; Pekmezci M; Perry A; Bollen AW; Phillips JJ; Braunstein SE; Raleigh DR; Theodosopoulos P; Aghi MK; Chang EF; Hervey-Jumper SL; Costello JF; de Groot J; Butowski NA; Clarke JL; Chang SM; Berger MS; Molinaro AM; Solomon DA
Acta Neuropathol; 2023 Dec; 147(1):3. PubMed ID: 38079020
[TBL] [Abstract] [Full Text] [Related]
[Next]
